Global Sulphonamides Market Size To Worth USD 189.87 Million By 2033 | CAGR of 4.71%
Category: HealthcareGlobal Sulphonamides Market Size To Worth USD 189.87 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Sulphonamides Market Size is Expected to Grow from USD 119.82 Million in 2023 to USD 189.87 Million by 2033, at a CAGR of 4.71% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 257 pages with 126 Market data tables and figures & charts from the report on the "Global Sulphonamides Market Size, Share, and COVID-19 Impact Analysis, By Medication Type (Generics and Branded), By Route of Administration (Topical, Oral, and Others), By Application (Respiratory Tract Infection (RTI), Gastrointestinal Infection (GIT), Urinary Tract Infection (UTI), Skin Infection, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/sulphonamides-market
The sulphonamides market focuses on developing, producing, and commercializing sulphonamide drugs for treating bacterial infections. These drugs, also known as sulfa drugs, are effective antibacterial agents that inhibit folic acid production in bacteria. The market growth is driven by government initiatives like the "Production Linked Incentives (PLI) Scheme" in India, which promotes domestic manufacturing of key starting materials, drug intermediates, and active pharmaceutical ingredients. The increasing demand for sulphonamides due to bacterial infections and urinary tract infections, which affect 150 million people annually, has also contributed to the market growth. Innovations in drug discovery techniques and the rise in generic medication production further drive the market growth. The increasing prevalence of infectious diseases increased the need for sulphonamides, which hold a significant position in the pharmaceutical industry. The broad-spectrum activity of sulphonamides, their cost-effectiveness, and their wide range of applications, along with self-medication trends and increased over-the-counter use, contribute to the market size. Advancements in drug discovery and development methods additionally contribute to market growth. However, stringent government regulations and patent expirations hamper the market growth.
The branded segment held the largest share in 2023 and is predicted to grow at a CAGR of 4.56% during the predicted period.
Based on the medication type, the global sulphonamides market is categorized as generics and branded. Among these, the branded segment held the largest share in 2023 and is predicted to grow at a CAGR of 4.56% during the predicted period. The growth of this segment is driven by patient convenience, reliability, quality standards, brand recognition, credibility, widespread healthcare recommendations, extensive clinical trials, and prescriptions for chronic conditions.
The oral segment accounted for the highest share in 2023 and is predicted to grow at a remarkable CAGR throughout the projected timeframe.
Based on the route of administration, the global sulphonamides market is categorized as topical, oral, and others. Among these, the oral segment accounted for the highest share in 2023 and is predicted to grow at a remarkable CAGR throughout the projected timeframe. The segment expansion is driven by its efficacy, patient compliance, strict regulations, simple formulation, cost-effectiveness, ease of administration, accessibility, benefits for middle and low-income countries, geriatric populations, stability of sugar taste, non-invasiveness, targeted drug delivery, and chemical and physical stability.
The skin infection segment held the greatest market share of 24.78% in 2023 and is anticipated to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global sulphonamides market is categorized into respiratory tract infection (RTI), gastrointestinal infection (GIT), urinary tract infection (UTI), skin infection, and others. Among these, the skin infection segment held the greatest market share of 24.78% in 2023 and is anticipated to grow at a significant CAGR throughout the projected timeframe. The growth of the skin infection segment is driven by increasing cases of dermatitis, acne, burns, and itching, with atopic dermatitis affecting 2.6% of the global population and 204.05 million people, according to the British Journal of Dermatology.
The hospital pharmacies segment dominated the global sulphonamides market in 2023 and is predicted to grow at a substantial CAGR throughout the projected timeframe.
Based on the distribution channel, the global sulphonamides market is categorized as retail pharmacies, hospital pharmacies, and online pharmacies. Among these, the hospital pharmacies segment dominated the global sulphonamides market in 2023 and is predicted to grow at a substantial CAGR throughout the projected timeframe. The segmental expansion is ascribed to the wide accessibility of sulphonamides stock, collaborations with distributors, healthcare associations, critical care drugs, personalized medications, and patient counseling facilities.
North America is expected to hold the greatest share of the global sulphonamides market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global sulphonamides market over the forecast period. Advanced technology, antibiotic usage, infection rates, and medical research are driving growth in the US and Canada. The US and Canada's leading pharmaceutical industry and research sector, producing novel sulphonamide formulations and treatments, are expected to drive market growth in North America, establishing itself as a significant player in the region.
Asia Pacific is predicted to hold the fastest-growing region of the global sulphonamides market throughout the estimated period. The Asia Pacific region's growing population and high infectious disease prevalence present significant growth opportunities for the sulphonamides sector. Countries like China, India, and Japan are investing in healthcare, improving infrastructure, and expanding services. Developing nations like South Korea, Brazil, India, and Mexico also have potential growth prospects due to their large patient bases and improved healthcare infrastructure.
Major key players in the global sulphonamides market are Cipla Limited., Monarch Pharmaceuticals, Lexine Tenochem Pvt. Ltd., Glenmarke Pharma Ltd., Teva Pharmaceuticals Ltd., Glaxo Smith Kline PLC, Cadila Pharmaceuticals Ltd., Allergan, Amneal Pharmaceuticals LLC, Dr. Reddy’s Laboratories, Pfizer, Aurobindo Pharma, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In April 2024, Atteeque Ahmed and et al. reported that in-vitro ins-silico screening of acryl pyrazole sulfonamides showed antidiabetic activity by inhibiting the alpha-glucosidase enzyme. This research study is published in the Journal, Frontiers in Chemistry.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global sulphonamides market based on the below-mentioned segments:
Global Sulphonamides Market, By Medication Type
- Generics
- Branded
Global Sulphonamides Market, By Route of Administration
- Topical
- Oral
- Others
Global Sulphonamides Market, By Application
- Respiratory Tract Infection (RIT)
- Gastrointestinal Infection (GIT)
- Urinary Tract Infection (UIT)
- Skin Infection
- Others
Global Sulphonamides Market, By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Global Sulphonamides Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?